Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Other financing activities: 2017-2024

Historic Other financing activities for Solid Biosciences (SLDB) over the last 1 years, with Jun 2024 value amounting to $286,000.

  • Solid Biosciences' Other financing activities was N/A to $286,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $5.6 million, marking a year-over-year change of. This contributed to the annual value of $5.1 million for FY2024, which is N/A change from last year.
  • Per Solid Biosciences' latest filing, its Other financing activities stood at $286,000 for Q2 2024, which was down 94.07% from $4.8 million recorded in Q1 2024.
  • Solid Biosciences' Other financing activities' 5-year high stood at $4.8 million during Q1 2024, with a 5-year trough of $286,000 in Q2 2024.
  • Moreover, its 1-year median value for Other financing activities was $2.6 million (2024), whereas its average is $2.6 million.